Pharma IQ | 06/07/2016
As the UK preps to make its decision on whether to retain its EU membership, many are pondering what chain reactions could lie in wait behind either choice. Especially as the United Kingdom’s pharma and life science industries are keystones for Europe. According to statistics from BMI Research, last year the UK earned the second largest amount of pharmaceutical sales within the EU single market. (1) Pharma and Cold Chain IQ explores the varying views and predictions on the potential outcom...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
SmartLab Exchange Europe
February 25 - 26, 2025
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange USA 2025
08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now |
View Agenda |
Learn More